Login / Signup

Correction to: GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data.

Andrei Carvalho SpositoOtávio BerwangerLuiz Sérgio F de CarvalhoJosé Francisco Kerr Saraiva
Published in: Cardiovascular diabetology (2019)
Following publication of the original article [1], based on the authors review, the GLP1 receptor agonists in type 2 diabetes published in Cardiovascular Diabetology, a meta-analysis of GLP-1 and non-GLP-1 based therapies was performed on cardiovascular outcomes.
Keyphrases
  • type diabetes
  • glycemic control
  • cardiovascular disease
  • insulin resistance
  • electronic health record
  • randomized controlled trial
  • systematic review
  • big data
  • adipose tissue
  • artificial intelligence
  • deep learning